Boston University and GSK collaborate to tackle pulmonary fibrosis

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center (BMC) have announced a new collaboration with the global biopharma company GSK to advance innovative research focused on developing cutting-edge models to study and treat lung diseases like pulmonary fibrosis.

Opinion | COVID’s Latest Adaptation: It Has Lulled us to Sleep

Simborg is a retired physician and a medical informatics expert. I’m an 83-year-old retired physician. I let my medical license expire over a decade ago

February 16, 2024

Natural proteins may offer new way to treat covid-19 and autoimmune disorders

Some people naturally have higher levels of proteins that protect them from covid-19. New studies at Umeå University of our immune system may pave the

December 2, 2024

Endoscopic Ablation Reduces ‘Hunger Hormone,’ Yields Weight Loss in Early Trial

WASHINGTON — Endoscopic gastric fundus mucosal ablation (GFMA) as a means of reducing production of the hunger-modulating hormone ghrelin was technically feasible and safe in

May 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.